Profile data is unavailable for this security.
About the company
CStone Pharmaceuticals is a China-based investment holding company. Through its subsidiaries, the Company is primarily engaged in development, manufacturing and sales of biopharmaceutical products. Its main products include immuno-oncology drugs and molecularly targeted drugs. The Company conducts its businesses mainly in domestic market.
- Revenue in HKD (TTM)500.53m
- Net income in HKD-396.28m
- Incorporated2015
- Employees230.00
- LocationCStone Pharmaceuticals1000 Zhangheng Road Bldg 25Pudong New DistrictSUZHOU 200072ChinaCHN
- Phone+86 51 287186550
- Websitehttps://www.cstonepharma.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jilin Provnc Hnn Chnglng Bio-pharm CoLtd | 908.10m | 159.93m | 885.20m | 848.00 | 5.53 | 0.5541 | 7.23 | 0.9748 | 0.2855 | 0.2855 | 1.62 | 2.85 | 0.3587 | 2.18 | 2.94 | 1,070,873.00 | 6.32 | 7.67 | 9.12 | 10.48 | 69.40 | 78.79 | 17.61 | 20.68 | 1.51 | -- | 0.0515 | 7.22 | -0.0049 | 5.38 | -23.43 | -1.67 | -1.14 | -- |
| Brii Biosciences Ltd | 665.80k | -188.66m | 1.01bn | 128.00 | -- | 0.2991 | -- | 1,512.33 | -0.2594 | -0.2594 | 0.0009 | 4.61 | 0.0002 | -- | -- | 5,201.54 | -5.60 | -- | -5.84 | -- | -- | -- | -29,881.69 | -- | -- | -- | 0.001 | -- | -98.80 | -- | 63.90 | -- | -- | -- |
| Zhongzhi Pharmaceutical Holdings Ltd | 2.21bn | 175.65m | 1.04bn | 2.64k | 5.79 | 0.9159 | 3.61 | 0.4685 | 0.2074 | 0.2074 | 2.61 | 1.31 | 1.12 | 2.53 | 10.54 | 836,899.80 | 8.95 | 7.69 | 14.15 | 11.75 | 59.73 | 60.56 | 8.01 | 6.73 | 0.894 | -- | 0.1424 | 42.46 | 12.26 | 12.41 | 53.00 | 13.86 | 17.65 | 3.22 |
| Hbm Holdings Ltd | 699.25m | 178.11m | 1.05bn | 177.00 | 5.61 | 1.07 | 4.89 | 1.50 | 0.2423 | 0.2423 | 0.9527 | 1.28 | 0.3886 | 3.90 | 3.01 | 3,950,578.00 | 9.88 | -54.61 | 14.13 | -66.04 | 97.73 | 97.81 | 25.43 | -400.28 | 3.28 | 6.98 | 0.3556 | -- | 120.13 | 127.06 | 116.61 | -- | -12.62 | -- |
| Jacobson Pharma Corporation Ltd | 1.68bn | 212.16m | 1.14bn | 1.59k | 5.12 | 0.4779 | 2.88 | 0.6774 | 0.1112 | 0.1409 | 0.8822 | 1.19 | 0.3722 | 2.87 | 7.50 | 940,829.50 | 5.16 | 4.91 | 6.61 | 6.60 | 42.05 | 41.81 | 13.85 | 14.32 | 1.01 | 5.62 | 0.3646 | 35.97 | 11.91 | 2.89 | 41.30 | 4.42 | -6.22 | 6.39 |
| VIVA Biotech Holdings | 2.33bn | -125.30m | 1.34bn | 2.08k | -- | 0.3337 | 11.10 | 0.5761 | -0.0637 | -0.0637 | 1.20 | 1.86 | 0.2805 | 4.84 | 5.13 | 1,119,912.00 | -1.30 | -1.39 | -1.79 | -1.68 | 34.26 | 34.81 | -4.63 | -5.44 | 1.15 | 0.035 | 0.3412 | -- | -9.42 | 59.31 | 78.03 | -- | -- | -- |
| Essex Bio-Technology Ltd | 1.71bn | 275.26m | 1.36bn | 1.48k | 5.10 | 0.7051 | 4.05 | 0.7948 | 0.4689 | 0.4689 | 2.87 | 3.39 | 0.6161 | 2.28 | 3.35 | 1,152,300.00 | 9.94 | 11.20 | 13.21 | 14.73 | 90.20 | 86.01 | 16.13 | 19.77 | 1.46 | -- | 0.1326 | 16.16 | 29.51 | 7.72 | 22.11 | 3.56 | 7.29 | 7.39 |
| CStone Pharmaceuticals | 500.53m | -396.28m | 1.41bn | 230.00 | -- | 2.87 | -- | 2.82 | -0.3142 | -0.3142 | 0.3963 | 0.3839 | 0.2811 | 2.44 | 3.72 | 2,176,200.00 | -22.25 | -54.76 | -48.85 | -81.68 | 65.60 | -- | -79.17 | -301.62 | 1.44 | -- | 0.4431 | -- | -3.64 | -- | 59.32 | -- | 52.42 | -- |
| TOT Biopharm International Co Ltd | 842.37m | -40.74m | 1.43bn | 551.00 | -- | 1.93 | 271.94 | 1.70 | -0.0562 | -0.0562 | 1.16 | 0.9589 | 0.5808 | 1.87 | 8.03 | 1,528,797.00 | -2.81 | -20.01 | -3.72 | -25.21 | 73.53 | 74.74 | -4.84 | -68.53 | 1.48 | -4.60 | 0.3348 | -- | 76.54 | 81.88 | 24.36 | -- | 21.04 | -- |
| Ascletis Pharma Inc | 61.07m | -156.16m | 1.44bn | 219.00 | -- | 0.6027 | -- | 23.55 | -0.1468 | -0.1468 | 0.0569 | 2.36 | 0.022 | 2.30 | 3.86 | 278,867.70 | -5.62 | -6.43 | -5.91 | -6.64 | 45.92 | 35.67 | -255.70 | -243.38 | 16.54 | -6.09 | 0.0036 | -- | 4.63 | -19.39 | 54.04 | -- | -- | -- |
| Wuhan YZY Biopharma Co Ltd | -100.00bn | -100.00bn | 1.44bn | 123.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -1.50 | -- | -- | -- |
| Jacobio Pharmaceuticals Group Co Ltd | 68.54m | -387.52m | 1.47bn | 301.00 | -- | 1.27 | -- | 21.49 | -0.5013 | -0.5013 | 0.0887 | 1.46 | 0.0419 | -- | 5.21 | 227,719.70 | -23.66 | -45.76 | -26.86 | -49.30 | 5.04 | -- | -565.36 | -372.22 | -- | -- | 0.1636 | -- | -33.66 | -- | 3.43 | -- | 19.18 | -- |
| Mabpharm Ltd | 94.05m | -225.91m | 1.63bn | 347.00 | -- | 7.36 | -- | 17.32 | -0.0548 | -0.0548 | 0.0228 | 0.0537 | 0.0893 | 0.1176 | 6.02 | 271,049.90 | -21.44 | -21.42 | -28.92 | -27.49 | 86.32 | -- | -240.19 | -486.40 | 0.7596 | -19.03 | 0.5591 | -- | 55.87 | -- | 0.694 | -- | -26.85 | -- |
| Hua Medicine | 82.67m | -227.94m | 1.68bn | 177.00 | -- | 14.26 | -- | 20.30 | -0.2332 | -0.2332 | 0.0846 | 0.1115 | 0.0538 | 1.69 | 1.98 | 467,055.80 | -14.84 | -25.61 | -17.56 | -28.81 | 48.78 | -- | -275.73 | -1,654.70 | 6.06 | -- | 0.6238 | -- | 335.31 | -- | -3.80 | -- | -- | -- |
| Immunotech Biopharm Ltd | 0.00 | -361.30m | 1.77bn | 210.00 | -- | 9.42 | -- | -- | -0.7021 | -0.7021 | 0.00 | 0.3641 | 0.00 | -- | -- | 0.00 | -38.88 | -37.42 | -50.88 | -45.48 | -- | -- | -- | -- | 1.03 | -1.97 | 0.4327 | -- | -- | -- | -5.25 | -- | -- | -- |
| Dawnrays Pharmaceutical (Holdings) Ltd | 1.24bn | 351.78m | 1.77bn | 1.14k | 5.04 | 0.5747 | 3.92 | 1.43 | 0.234 | 0.234 | 0.8267 | 2.05 | 0.3156 | 2.31 | 6.37 | 1,086,777.00 | 8.85 | 9.89 | 11.36 | 12.49 | 54.60 | 56.69 | 28.03 | 27.89 | 2.26 | 28.89 | 0.0405 | 35.33 | -9.90 | 3.94 | -8.95 | 1.41 | 63.92 | 2.00 |
Data as of May 03 2024. Currency figures normalised to CStone Pharmaceuticals's reporting currency: Hong Kong Dollar HKD
2.35%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 05 Apr 2024 | 17.63m | 1.37% |
| Bosera Asset Management Co., Ltd.as of 31 Dec 2022 | 9.27m | 0.72% |
| Templeton Asset Management Ltd.as of 31 Dec 2023 | 2.28m | 0.18% |
| Xinyuan Asset Management Co., Ltd.as of 30 Jun 2023 | 745.00k | 0.06% |
| SSgA Funds Management, Inc.as of 04 Apr 2024 | 144.50k | 0.01% |
| Vanguard Global Advisers LLCas of 31 Mar 2024 | 59.00k | 0.01% |
| Ping An Fund Management Co., Ltd.as of 30 Jun 2023 | 0.00 | 0.00% |
| E Fund Asset Management Co. Ltd.as of 30 Jun 2023 | 0.00 | 0.00% |
| Platinum Investment Management Ltd.as of 31 Dec 2023 | 0.00 | 0.00% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 0.00 | 0.00% |
More ▼
Data from 30 Jun 2023 - 22 Apr 2024Source: FactSet Research Systems Inc.
